Insulin therapy in type 2 diabetes
38 results
1 - 38
Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control- Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus
- Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus: Cochrane systematic review
- (Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
- Self‐monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
- Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis
- Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
- Insulin for the treatment of women with gestational diabetes
- Sulphonylurea monotherapy for patients with type 2 diabetes mellitus: Cochrane systematic review
- Enhanced glucose control for preventing and treating diabetic neuropathy
- Continuous glucose monitoring systems for type 1 diabetes mellitus
- Pioglitazone for type 2 diabetes mellitus
- Inhaled insulin in diabetes mellitus: Cochrane systematic review
- Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus
- Rosiglitazone for type 2 diabetes mellitus
- Interventions for latent autoimmune diabetes (LADA) in adults: Cochrane systematic review
- Colesevelam for type 2 diabetes mellitus
- Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
- Exercise for diabetic pregnant women
- Dietary supplementation with myo‐inositol in women during pregnancy for treating gestational diabetes
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
- Different intensities of glycaemic control for women with gestational diabetes mellitus
- Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
- Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes
- Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
- Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes
- Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
- Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health
- Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes